Table 1. Clinical and Demographic Characteristics of all Participants, Including Nonheart Failure Group Versus Heart Failure Group.
Variable | All Patients(n=100) | Non-HF Group I (n=76) | HF Group II (n =24) | P Value |
---|---|---|---|---|
Age | 60.21±11.80 | 57.56±11.67 | 68.58±7.73 | <0.001* |
Male sex | 50 (50%) | 39 (51.4%) | 11 (45.8%) | 0.815 |
Female sex | 50 (50%) | 37 (48.6%) | 13 (54.1%) | 0.830 |
HTN | 46 (46%) | 28 (36.8%) | 18 (75%) | 0.002* |
Obese | 50 (50%) | 37 (48.6%) | 13 (54.1%) | 0.815 |
Smoking | 45 (45%) | 31 (40.7%) | 14 (58.3%) | 0.161 |
Dyslipidemia | 62 (62%) | 51 (67.1%) | 11 (45.8%) | 0.090 |
FH ofIHD | 26 (26%) | 3 (3.9%) | 4 (16.6%) | 0.055 |
COVID | 8 (8%) | 2 (2.6%) | 6 (25%) | 0.002* |
HTN: hypertension, FH: family history; IHD: ischemic heart disease; COVID: coronavirus disease, * Indicate statistical significance.